This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yan, P. Articles by Guillou, L. Search for Related Content PubMed PubMed Citation Articles by Yan, P. Articles by Guillou, L.

Telomerase Activity and Human Telomerase Reverse Transcriptase mRNA Expression in Soft Tissue Tumors

Correlation with Grade, Histology, and Proliferative Activity

University Institute of Pathology, CH-1011 Lausanne, Switzerland [P. Y., J. B., F. T. B., L. G.]; and Bergonié Institute and University of Bordeaux II, 33076 Bordeaux, France [J-M. C.]

Telomerase activity (TA) is detected in most human cancers but, with few exceptions, not in normal somatic cells. Little is known about TA in soft tissue tumors. We have examined a series of benign and malignant soft tissue tumors for TA using the telomerase repeat amplification protocol assay. Analysis of the expression of the human telomerase reverse transcriptase was also carried out using RT-PCR. TA was undetectable in benign lesions (15 of 15) and low-grade sarcomas (6 of 6) and was detectable in 50% (19 of 38) of intermediate-/high-grade sarcomas. Although the presence of TA in soft tissue tumors is synonymous with malignancy, it is neither a reliable method in making the distinction between reactive/benign and malignant (especially low-grade) lesions nor a reliable marker of tumor aggressiveness. Leiomyosarcomas and storiform/pleomorphic malignant fibrous histiocytomas rarely showed TA, irrespective of their grade. A strong correlation between human telomerase reverse transcriptase mRNA expression and TA was observed, supporting the close relationship between both parameters. No significant relationship was observed between proliferative activity (as assessed by MIB-1 immunolabeling) and TA. We verified that the absence of telomerase expression was not due to the presence of telomerase inhibitors and therefore alternative mechanism(s) for cell immortalization, yet to be determined, seem to be involved in the development and/or maintenance of some soft tissue sarcomas.

This article has been cited by other articles:

				J. Kamizono, S. Nagano, Y. Murofushi, S. Komiya, H. Fujiwara, T. Matsuishi, and K.-i. Kosai Survivin-Responsive Conditionally Replicating Adenovirus Exhibits Cancer-Specific and Efficient Viral Replication Cancer Res., June 15, 2005; 65(12): 5284 - 5291. [Abstract] [Full Text] [PDF]

				S. Chang, C. M. Khoo, M. L. Naylor, R. S. Maser, and R. A. DePinho Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression Genes & Dev., January 1, 2003; 17(1): 88 - 100. [Abstract] [Full Text] [PDF]

				I. Guilleret, P. Yan, L. Guillou, R. Braunschweig, J.-M. Coindre, and J. Benhattar The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation Carcinogenesis, December 1, 2002; 23(12): 2025 - 2030. [Abstract] [Full Text] [PDF]

				X. q. Chen, H. Bonnefoi, M.-F. Pelte, J. Lyautey, C. Lederrey, S. Movarekhi, P. Schaeffer, H. E. Mulcahy, P. Meyer, M. Stroun, et al. Telomerase RNA as a Detection Marker in the Serum of Breast Cancer Patients Clin. Cancer Res., October 1, 2000; 6(10): 3823 - 3826. [Abstract] [Full Text]